Ashika D Maharaj1, Liane Ioannou1, Daniel Croagh2, John Zalcberg1, Rachel E Neale3, David Goldstein4, Neil Merrett5, James G Kench6, Kate White7, Charles H C Pilgrim8, Lorraine Chantrill9, Peter Cosman10, Andrew Kneebone11, Lara Lipton12, Mehrdad Nikfarjam13, Jennifer Philip14, Charbel Sandroussi15, Peter Tagkalidis16, Richard Chye17, Koroush S Haghighi18, Jaswinder Samra19, Sue M Evans20. 1. Department of Epidemiology and Preventative Medicine, Monash University, Melbourne, Australia. 2. Monash University, Melbourne, Victoria, Australia; Monash Health, Clayton, Victoria, Australia; Epworth Healthcare, Richmond, Australia. 3. QIMR Berghofer Medical Research Institute, Herston, Australia. 4. Prince of Wales Clinical School, UNSW Medicine, NSW, Australia. 5. School of Medicine, Western Sydney University, NSW, Australia. 6. Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Central Clinical School, University of Sydney, NSW, Australia. 7. Sydney Nursing School, University of Sydney, Australia. 8. Alfred Health, Melbourne, Victoria, Australia; Cabrini, Malvern, Victoria, Australia; Peninsula Health, Frankston, Victoria, Australia; Peninsula Private Hospital, Frankston, Victoria, Australia. 9. Kinghorn Cancer Centre, St Vincent's Hospital, NSW, Australia; Garvan Institute of Medical Research and University of New South Wales, NSW, Australia. 10. School of Medicine, Faculty of Science, Medicine & Health, University of Wollongong, NSW, Australia. 11. Northern Clinical School, University of Sydney, Australia. 12. Cabrini, Malvern, Victoria, Australia; Royal Melbourne Hospital, Parkville, Victoria, Australia; Western Health, Sunshine, Victoria, Australia. 13. Melbourne University, Parkville, Victoria, Australia; Austin Health, Heidelberg, Australia. 14. Melbourne University, Parkville, Victoria, Australia. 15. Central Clinical School, University of Sydney, NSW, Australia. 16. Alfred Health, Melbourne, Victoria, Australia; Royal Melbourne Hospital, Parkville, Victoria, Australia. 17. St Vincent's Private Hospital, Darlinghurst, NSW, Australia; Faculty of Health, University of Technology, NSW, Australia. 18. Prince of Wales Clinical School, UNSW Medicine, NSW, Australia; Kinghorn Cancer Centre, St Vincent's Hospital, NSW, Australia. 19. Department of Upper GI Surgery, Royal North Shore Hospital, NSW, Australia; Macquarie University Hospital, Macquarie University, Australia. 20. Department of Epidemiology and Preventative Medicine, Monash University, Melbourne, Australia. Electronic address: sue.evans@monash.edu.
Abstract
BACKGROUND: Best practise care optimises survival and quality of life in patients with pancreatic cancer (PC), but there is evidence of variability in management and suboptimal care for some patients. Monitoring practise is necessary to underpin improvement initiatives. We aimed to develop a core set of quality indicators that measure quality of care across the disease trajectory. METHODS: A modified, three-round Delphi survey was performed among experts with wide experience in PC care across three states in Australia. A total of 107 potential quality indicators were identified from the literature and divided into five areas: diagnosis and staging, surgery, other treatment, patient management and outcomes. A further six indicators were added by the panel, increasing potential quality indicators to 113. Rated on a scale of 1-9, indicators with high median importance and feasibility (score 7-9) and low disagreement (<1) were considered in the candidate set. RESULTS: From 113 potential quality indicators, 34 indicators met the inclusion criteria and 27 (7 diagnosis and staging, 5 surgical, 4 other treatment, 5 patient management, 6 outcome) were included in the final set. CONCLUSIONS: The developed indicator set can be applied as a tool for internal quality improvement, comparative quality reporting, public reporting and research in PC care.
BACKGROUND: Best practise care optimises survival and quality of life in patients with pancreatic cancer (PC), but there is evidence of variability in management and suboptimal care for some patients. Monitoring practise is necessary to underpin improvement initiatives. We aimed to develop a core set of quality indicators that measure quality of care across the disease trajectory. METHODS: A modified, three-round Delphi survey was performed among experts with wide experience in PC care across three states in Australia. A total of 107 potential quality indicators were identified from the literature and divided into five areas: diagnosis and staging, surgery, other treatment, patient management and outcomes. A further six indicators were added by the panel, increasing potential quality indicators to 113. Rated on a scale of 1-9, indicators with high median importance and feasibility (score 7-9) and low disagreement (<1) were considered in the candidate set. RESULTS: From 113 potential quality indicators, 34 indicators met the inclusion criteria and 27 (7 diagnosis and staging, 5 surgical, 4 other treatment, 5 patient management, 6 outcome) were included in the final set. CONCLUSIONS: The developed indicator set can be applied as a tool for internal quality improvement, comparative quality reporting, public reporting and research in PC care.
Authors: Misa Matsuyama; Mythily Sachchithananthan; Robyn Leonard; Michael Besser; Anna K Nowak; Donna Truran; Claire M Vajdic; John R Zalcberg; Hui K Gan; Craig Gedye; Winny Varikatt; Eng-Siew Koh; Ganessan Kichenadasse; Hao-Wen Sim; Nicholas G Gottardo; Desma Spyridopoulos; Rosalind L Jeffree Journal: Neurooncol Pract Date: 2021-08-31
Authors: Ashika D Maharaj; Jennifer F Holland; Ri O Scarborough; Sue M Evans; Liane J Ioannou; Wendy Brown; Daniel G Croagh; Charles H C Pilgrim; James G Kench; Lara R Lipton; Trevor Leong; John J McNeil; Mehrdad Nikfarjam; Ahmad Aly; Paul R Burton; Paul A Cashin; Julie Chu; Cuong P Duong; Peter Evans; David Goldstein; Andrew Haydon; Michael W Hii; Brett P F Knowles; Neil D Merrett; Michael Michael; Rachel E Neale; Jennifer Philip; Ian W T Porter; Marty Smith; John Spillane; Peter P Tagkalidis; John R Zalcberg Journal: BMJ Open Date: 2019-09-30 Impact factor: 2.692
Authors: Braden Woodhouse; Sharon Pattison; Eva Segelov; Simron Singh; Kate Parker; Grace Kong; William Macdonald; David Wyld; Goswin Meyer-Rochow; Nick Pavlakis; Siobhan Conroy; Vallerie Gordon; Jonathan Koea; Nicole Kramer; Michael Michael; Kate Wakelin; Tehmina Asif; Dorothy Lo; Timothy Price; Ben Lawrence Journal: J Clin Med Date: 2019-09-12 Impact factor: 4.241